Roble Belko & Company’s GSK GSK Stock Holding History

Roble Belko & Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$26K	Hold	685	–	–	﹤0.01%	221
2025 Q1	$27K	Hold	685	–	–	﹤0.01%	206
2024 Q4	$23K	Hold	685	–	–	﹤0.01%	208
2024 Q3	$28K	Sell	685 -2,160	-76%	-$88.3K	﹤0.01%	193
2024 Q2	$110K	Hold	2,845	–	–	0.02%	129
2024 Q1	$122K	Buy	2,845 +2,160	+315%	+$92.6K	0.02%	127
2023 Q4	$25K	Hold	685	–	–	﹤0.01%	188
2023 Q3	$25K	Hold	685	–	–	0.01%	172
2023 Q2	$24K	Hold	685	–	–	﹤0.01%	178
2023 Q1	$24K	Hold	685	–	–	﹤0.01%	190
2022 Q4	$24K	Hold	685	–	–	0.01%	196
2022 Q3	$20K	Buy	+685	New	+$20K	﹤0.01%	200
2022 Q2	–	Sell	-686	Closed	-$37K	–	346
2022 Q1	$37K	Hold	686	–	–	0.01%	180
2021 Q4	$38K	Hold	686	–	–	0.01%	171
2021 Q3	$33K	Hold	686	–	–	0.01%	166
2021 Q2	$34K	Hold	686	–	–	0.01%	178
2021 Q1	$31K	Hold	686	–	–	0.01%	175
2020 Q4	$32K	Hold	686	–	–	0.01%	159
2020 Q3	$32K	Hold	686	–	–	0.01%	153
2020 Q2	$35K	Hold	686	–	–	0.01%	159
2020 Q1	$32K	Hold	686	–	–	0.01%	159
2019 Q4	$40K	Hold	686	–	–	0.01%	161
2019 Q3	$37K	Sell	686 -647	-49%	-$34.9K	0.01%	158
2019 Q2	$67K	Hold	1,333	–	–	0.02%	134
2019 Q1	$70K	Hold	1,333	–	–	0.02%	106
2018 Q4	$64K	Hold	1,333	–	–	0.02%	105
2018 Q3	$67K	Hold	1,333	–	–	0.02%	97
2018 Q2	$67K	Hold	1,333	–	–	0.03%	99
2018 Q1	$65K	Hold	1,333	–	–	0.03%	111
2017 Q4	$59K	Hold	1,333	–	–	0.02%	109
2017 Q3	$68K	Hold	1,333	–	–	0.03%	89
2017 Q2	$72K	Sell	1,333 -510	-28%	-$27.5K	0.03%	86
2017 Q1	$97K	Hold	1,843	–	–	0.05%	73
2016 Q4	$89K	Hold	1,843	–	–	0.05%	77
2016 Q3	$99K	Hold	1,843	–	–	0.05%	74
2016 Q2	$100K	Sell	1,843 -457	-20%	-$24.8K	0.06%	78
2016 Q1	$117K	Buy	2,300 +510	+28%	+$25.9K	0.07%	59
2015 Q4	$90K	Hold	1,790	–	–	0.05%	64
2015 Q3	$86K	Hold	1,790	–	–	0.05%	69
2015 Q2	$93K	Hold	1,790	–	–	0.05%	72
2015 Q1	$103K	Buy	+1,790	New	+$103K	0.06%	68